Design, Synthesis, and Evaluation of Cytotoxic Effects of Functional Fatty Acid Derivatives as Potential

Maryam Hosseini1, Farzad Kobarfard1,2, Salimeh Amidi1

  • 1Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Insights

New fatty acid derivatives show potent anti-cancer activity against breast cancer cells. These docosahexaenoic acid (DHA) and linoleic acid (LA) compounds selectively kill cancer cells by inducing apoptosis, offering a promising therapeutic strategy.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Molecular Biology

Background:

  • Breast cancer is a leading cause of cancer mortality in women globally.
  • Essential fatty acids present a promising avenue for novel breast cancer therapeutics.
  • Current treatments for breast cancer have limitations, necessitating the development of new agents.

Purpose of the Study:

  • To synthesize novel derivatives of docosahexaenoic acid (DHA) and linoleic acid (LA).
  • To evaluate the in vitro anti-cancer properties of these synthesized derivatives against breast cancer cells.
  • To investigate the mechanism of action for the most potent derivatives.

Main Methods:

  • Synthesis of 16 novel fatty acid derivatives (14 LA/DHA, 2 ethylenediamine).
  • In vitro cytotoxicity assessment using MTT assay on MCF-7 breast cancer cells and HDFs.
  • Apoptosis induction analysis via Annexin V-FITC/PI flow cytometry.

Main Results:

  • All synthesized DHA and LA derivatives exhibited significant cytotoxic effects on MCF-7 cells.
  • Compounds D3 and L3 demonstrated the highest potency with EC50 values of 15.96 μM and 24.64 μM, respectively.
  • Selective toxicity was observed, with no significant impact on normal human dermal fibroblasts (HDFs).

Conclusions:

  • Functional fatty acid derivatives effectively reduce breast cancer cell viability.
  • Compounds D3 and L3 induce apoptosis in cancer cells, suggesting a targeted cell death mechanism.
  • These novel derivatives represent potential lead compounds for future breast cancer therapy development.